Therapeutic opportunities in the B7/CD28 family of ligands and receptors

被引：32

作者：

Carreno, BM ^{[1
]}

Carter, LL ^{[1
]}

Collins, M ^{[1
]}

机构：

[1] Wyeth Res, Inflammat, Cambridge, MA 02140 USA

来源：

CURRENT OPINION IN PHARMACOLOGY | 2005年 / 5卷 / 04期

关键词：

D O I：

10.1016/j.coph.2005.02.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent Phase I clinical studies using agonists and antagonists of the CD28/CTLA-4/B7 pathway have shown promise in inflammatory diseases and cancer.

引用

收藏

页码：424 / 430

页数：7

相关论文

共 74 条

[21] High-affinity small molecule inhibitors of T cell costimulation: Compounds for immunotherapy [J].

Huxley, P ;

Sutton, DH ;

Debnam, P ;

Matthews, IR ;

Brewer, JE ;

Rose, J ;

Trickett, M ;

Williams, DD ;

Andersen, TB ;

Classon, BJ .

CHEMISTRY & BIOLOGY, 2004, 11 (12) :1651-1658

[22] Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis [J].

Iwai, H ;

Abe, M ;

Hirose, S ;

Tsushima, F ;

Tezuka, K ;

Akiba, H ;

Yagita, H ;

Okumura, K ;

Kohsaka, H ;

Miyasaka, N ;

Azuma, M .

JOURNAL OF IMMUNOLOGY, 2003, 171 (06) :2848-2854

[23] Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation [J].

Iwai, H ;

Kozono, Y ;

Hirose, S ;

Akiba, H ;

Yagita, H ;

Okumura, K ;

Kohsaka, H ;

Miyasaka, N ;

Azuma, M .

JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4332-4339

[24] PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells [J].

Iwai, Y ;

Terawaki, S ;

Honjo, T .

INTERNATIONAL IMMUNOLOGY, 2005, 17 (02) :133-144

[25] Blockade of B7-H1 suppresses intestinal inflammation the development of chronic [J].

Kanai, T ;

Totsuka, T ;

Uraushihara, K ;

Makita, S ;

Nakamura, T ;

Koganei, K ;

Fukushima, T ;

Akiba, H ;

Yagita, H ;

Okumura, K ;

Machida, T ;

Iwai, H ;

Azuma, M ;

Chen, LP ;

Watanabe, M .

JOURNAL OF IMMUNOLOGY, 2003, 171 (08) :4156-4163

[26] The roles of the new negative T cell costimulatory pathways in regulating autoimmunity [J].

Khoury, SJ ;

Sayegh, MH .

IMMUNITY, 2004, 20 (05) :529-538

[27] B7-h1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression [J].

Konishi, J ;

Yamazaki, K ;

Azuma, M ;

Kinoshita, I ;

Dosaka-Akita, H ;

Nishimura, M .

CLINICAL CANCER RESEARCH, 2004, 10 (15) :5094-5100

[28] Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig [J].

Kremer, JM ;

Westhovens, R ;

Leon, M ;

Di Giorgio, E ;

Alten, R ;

Steinfeld, S ;

Russell, A ;

Dougados, M ;

Emery, P ;

Nuamah, IF ;

Williams, GR ;

Becker, JC ;

Hagerty, DT ;

Moreland, LW .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1907-1915

[29] Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss [J].

Ling, V ;

Wu, PW ;

Spaulding, V ;

Kieleczawa, J ;

Luxenberg, D ;

Carreno, BM ;

Collins, M .

GENOMICS, 2003, 82 (03) :365-377

[30] Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells [J].

Loke, P ;

Allison, JP .

ARTHRITIS RESEARCH & THERAPY, 2004, 6 (05) :208-214

← 1 2 3 4 5 6 7 8 →